1. Home
  2. TASK vs HELP Comparison

TASK vs HELP Comparison

Compare TASK & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TASK

TaskUs Inc.

N/A

Current Price

$8.32

Market Cap

755.5M

Sector

Technology

ML Signal

N/A

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

N/A

Current Price

$10.50

Market Cap

862.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TASK
HELP
Founded
2008
2019
Country
United States
Canada
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
755.5M
862.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
TASK
HELP
Price
$8.32
$10.50
Analyst Decision
Hold
Strong Buy
Analyst Count
8
11
Target Price
$8.50
★ $41.54
AVG Volume (30 Days)
214.1K
★ 1.4M
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 120.00
N/A
EPS
★ 0.50
N/A
Revenue
N/A
N/A
Revenue This Year
$4.48
N/A
Revenue Next Year
$6.42
N/A
P/E Ratio
$16.18
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.47
$3.76
52 Week High
$13.73
$15.15

Technical Indicators

Market Signals
Indicator
TASK
HELP
Relative Strength Index (RSI) 52.09 44.49
Support Level $7.50 $9.97
Resistance Level $8.72 $11.74
Average True Range (ATR) 0.31 0.83
MACD -0.03 0.04
Stochastic Oscillator 38.20 42.61

Price Performance

Historical Comparison
TASK
HELP

About TASK TaskUs Inc.

TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: